CDER Adds Gaucher Disease to 2017 Guidance Agenda Post author:Sam Post published:April 20, 2017 Post category:Drug Industry Daily CDER updated its guidance agenda for 2017, adding an item on Gaucher Disease. Source: Drug Industry Daily You Might Also Like FDA Denies Petition to Pull EUAs for Moderna, J&J COVID-19 Vaccines October 26, 2021 Generic Drugmakers Denied Rehearing on Validity of Vimpat Patent August 27, 2018 Democrats to Meet With Senate Parliamentarian Over Build Back Better December 3, 2021
